CD8A and hepatocellular carcinoma: However, in the treatment of DCs with exosomes derived from orthotopic hepatocellular carcinoma, model cells enhanced the number of CD8+T cells but decreased Tregs, with a significantly elevated number of PD-1+CD8+T cells [130].